Topic: Genomics

One challenge of developing a drug for a disease with no approved therapies is that […]

Scientists at Penn State have developed a microneedle bandage that can rapidly stop bleeding. Uncontrolled […]

  .The expanse of disease-causing proteins is fertile hunting ground for drug research. Many biotech […]

Bladder cancer can be treated with several types of drugs. Gene therapy is now part […]

Fractyl Health today announced positive preclinical proof-of-concept data in an animal model for its gene […]

Cell therapy has broken new therapeutic ground, but the progress of this drug class in […]

Researchers at Oregon State University created a new type of hyperthermic magnetic nanoparticle that is […]

Researchers at Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have developed a DNA toolbox […]

A new biotech company has formed to develop a potential gene therapy for a rare, […]

AMPEL BioSolutions has unveiled a new genetic precision medicine test that can predict heart disease at an early […]

Scientists at ETH Zurich in Switzerland have unveiled a technique that weaponizes bacterial cells against […]

Scientists at Oregon State University have developed a new treatment for COVID-19. The technology is […]

Researchers at Hokkaido University in Japan have developed a biomarker test for Alzheimer’s disease that […]

Dive Brief: Becton Dickinson formed a partnership to co-sell and co-promote Magnolia Medical’s Steripath platform. Steripath is a […]

A team at the University of Illinois at Urbana-Champaign has developed a DNA net system […]

LogicBio’s lead gene-editing therapy is emerging from a clinical hold, cash reserves to support that […]

Dive Brief: Illumina has unveiled new technology designed to reduce the cost of sequencing a genome to $200. The […]

The European Commission’s conditional marketing authorization (CMA) approval in August of a novel gene therapy […]

Scientists at the University of New South Wales in Australia have developed a method to […]

Rejuvinate Bio is a gene therapy startup that seeks to reverse aging. In response to […]

New startup Spear Bio plans to commercialize ultrasensitive protein-detection technology from Harvard University’s Wyss Institute […]

Researchers at Johns Hopkins University have created tiny EEG caps for brain organoids. The team […]

One reason engineered viruses are used to deliver genetic medicines is that viruses are very […]

When proteins in the body are old or damaged, cells have a way to deal […]

The possibility of using our own cells to perform medical tasks within the body is […]

A team at the University of Minnesota developed a new technique that lets them view […]

Karkinos Healthcare, a technology-driven cancer care platform in India, has entered into a strategic partnership […]

Biogennix has announced that its DirectCell advanced bone grafting system has now been used in more than 500 […]

Human gut health is closely correlated with mental well-being, various degenerative diseases, and chronic inflammation. […]

Researchers at Columbia University School of Engineering and Applied Science developed an advanced organ-on-a-chip system […]

It will probably surprise no one that Covid-19 has pushed U.S. spending on medicines higher. […]

Scientists at Penn State developed a method to print a ‘bone’ construct during a surgical […]

Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a […]

Altos Labs just redefined big in biotech. Where to start? The $3 billion in investor support? The […]

Hologic (NSDQ:HOLX) announced today that it completed regulatory steps allowing it to make Panther Trax available […]

The Franklin Lakes, NJ-based company has announced eight deals this year, closing on Boston Scientific’s 10 deals announced in 2018.

The Novo Nordisk Foundation, the Broad Institute of MIT and Harvard have launched an initiative […]

The company plans to use the money to help expand its pipeline and scale. 

The engineered viruses used to deliver gene therapies can spark complications and they can’t be re-dosed. Ring Therapeutics says viruses that evolved with humans can be better viral vectors and the startup has raised $117 million in new financing to continue its research.